Literature DB >> 28328860

Ventilation during cardiopulmonary bypass for prevention of respiratory insufficiency: A meta-analysis of randomized controlled trials.

Dongmei Chi1, Chan Chen, Yu Shi, Wanyu Wang, Ye Ma, Ronghua Zhou, Hai Yu, Bin Liu.   

Abstract

BACKGROUND: Cardiopulmonary bypass (CPB) is necessary for most cardiac surgery, which may lead to postoperative lung injury. The objective of this paper is to systematically evaluate whether ventilation during CPB would benefit patients undergoing cardiac surgery.
METHODS: We searched randomized controlled trials (RCTs) through PubMed, Embase, and Cochrane Library from inception to October 2016. Eligible studies compared clinical outcomes of ventilation versus nonventilation during CPB in patients undergoing cardiac surgery. The primary outcome includes oxygenation index (PaO2/FiO2 ratio) or alveolar to arterial oxygen tension difference (AaDO2) immediately after weaning from bypass. The secondary outcomes include postoperative pulmonary complications (PPCs), shunt fraction (Qs/Qt), hospital stay, and AaDO2 4 hours after CPB.
RESULTS: Seventeen trials with 1162 patients were included in this meta-analysis. Ventilation during CPB significantly increased post-CPB PaO2/FiO2 ratio (mean difference [MD] = 21.84; 95% confidence interval [CI] = 1.30 to 42.37; P = 0.04; I = 75%) and reduced post-CPB AaDO2 (MD = -50.17; 95% CI = -71.36 to -28.99; P <0.00001; I = 74%). Qs/Qt immediately after weaning from CPB showed a significant difference between groups (MD = -3.24; 95% CI = -4.48 to -2.01; P <0.00001; I = 0%). Incidence of PPCs (odds ratio [OR] = 0.79; 95% CI = 0.42 to 1.48; P = 0.46; I = 37%) and hospital stay (MD = 0.09; 95% CI = -23 to 0.41; P = 0.58; I = 37%) did not differ significantly between groups.
CONCLUSION: Ventilation during CPB might improve post-CPB oxygenation and gas exchange in patients who underwent cardiac surgery. However, there is no sufficient evidence to show that ventilation during CPB could influence long-term prognosis of these patients. The beneficial effects of ventilation during CPB are requisite to be evaluated in powerful and well-designed RCTs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28328860      PMCID: PMC5371497          DOI: 10.1097/MD.0000000000006454

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Despite the improvement in perioperative management, the postoperative respiratory dysfunction is still a widely reported complication of cardiopulmonary bypass (CPB), leading to increased mortality and morbidity in cardiac surgery.[ Various strategies including perioperative management of mechanical ventilation (MV), restrictive transfusion, technical modifications of CPB, and medication administration such as steroids and aprotinin have been developed to reduce impairment of pulmonary function.[ Ventilation during CPB is an important element of MV management strategies and determined by anesthesiologists in the operation room. Continuous positive airway pressure (CPAP), low-volume ventilation, positive end-expiratory pressure (PEEP), and vital capacity maneuvers (VCMs) are adjustable parameters composing ventilation techniques. So far, available researches regarding whether ventilation during CPB could improve respiratory outcomes are still controversial. Some studies found that the application of CPAP during CPB was an effective adjunct.[ Gaudriot et al[ suggested that maintaining MV during CPB could diminish immune dysfunction after surgery. However, others reported that the utilization of CPAP did not show a significant difference compared with the controls when it came to attenuating the post-CPB impairment of lung function.[ Additionally, it has been reported that the application of low tidal volume (TV)–low frequency ventilation could decrease the occurrence of CPB-related lung injury because it could decrease inflammatory reactions and some negative immune markers such as interleukin 10 and tumor necrosis factor-α (TNF-α).[ But the protective function of continuous ventilation during CPB is still debatable because many studies found it is not a necessary technique for an improved respiratory outcome.[ To provide the latest and more convincing evidence, we systematically reviewed the present available literature to evaluate the efficacy and safety of ventilation during CPB in patients who were scheduled to undergo cardiac surgery.

Methods

Search strategy

This meta-analysis was performed in accordance with PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines.[ We searched PubMed, Embase, and Cochrane Library from inception to October 2016, without a language restriction. Two reviewers conducted the searching work independently and the other 2 helped to resolve the conflicts in the process and find out the missed studies identified through other sources manually. A list of the search terms used for each electronic database is presented in Fig. S1 (Supplemental content). There is no requirement for ethical approval and patient consent as this is a meta-analysis of published studies.

Selection criteria

Study inclusion criteria were as follows: patients: adult patients (≥18 years) scheduled to undergo cardiac surgery with CPB procedure; interventions: different ventilation strategies during CPB period including either CPAP or low TV ventilation (PEEP and VCMs were not necessary factors); control: patients did not receive any type of ventilation during CPB; outcomes: the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (PaO2/FiO2 ratio), alveolar to arterial oxygen tension difference (AaDO2), shunt fraction (Q/Q), postoperative pulmonary complications (PPCs), and duration of hospital stay. At least 1 primary outcome, that is, either PaO2/FiO2 or AaDO2, must be reported in the eligible cites. Design: randomized controlled trials (RCTs). Study exclusion criteria were as follows: the ventilation interventions carried out before or after the CPB period, or in the intensive care unit after surgery, or carried discontinuously (e.g., only intermittent mandatory ventilation at weaning from CPB); (the CPB procedure was not used in cardiac surgery; publication type: conference abstracts, corresponding to other trial reports, or reviews; the interventions of control group was not nonventilation during CPB; other reasons including sub-studies and small sample-sized studies (<10 patients).

Data abstraction and quality assessment

Two independent reviewers conducted data abstraction and quality assessment. Conflicts were solved by discussion. Data extracted from articles included the following: trial characteristics: author, year of publication, study design, surgery type, sample size, inclusion criteria, experimental, and control arms; overall average baseline patient characteristics: age, male percent, body mass index (BMI), length of CPB, and length of surgery; endpoints: relevant primary endpoints (PaO2/FiO2 and AaDO2) and recording time of primary endpoints; and relevant secondary endpoints: Q/Q, PPCs, length of hospital stay and others. The secondary outcomes were not analyzed unless the data were available in at least 3 trials. We assessed the risk of bias of all eligible studies according to the standard of Cochrane Collaboration. The studies were assessed from the following aspects: randomized sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other bias. In this way, the studies were assessed as low risk, high risk, and unclear risk.[

Quality of evidence

GRADE (Grades of Recommendation, Assessment, Development and Evaluation) system was used for assessment of evidence quality. The quality of evidence classified by GRADE system is in 1 of 4 levels: high, moderate, low, and very low. Meta-analysis based on RCTs starts as high-quality evidence, and the confidence may be decreased because of the following reasons: study limitation, inconsistency of results, indirectness of evidence, imprecision, and reporting bias.[

Statistical analysis

Outcomes of continuous variables were expressed as the mean with standard difference. Mean difference (MD) and 95% confidence interval (CI) were calculated. Outcomes of discontinuous variables presented with events and total patients. Odds ratio (OR) and 95% CI were figured up. The primary outcome referred to PaO2/FiO2 or AaDO2 immediately after weaning from CPB. The secondary outcome referred to the PPCs, hospital stay, Q/Q immediately after weaning from CPB, and AaDO2 4 hours after weaning from CPB. Homogeneity assumption was tested with I2 statistics. It is calculated as I2 = 100% × (Q – df)/Q, where Q is Cochran's heterogeneity statistic. Heterogeneity was suggested if P ≤0.10. An I2 value of 0%–24.9% indicated no heterogeneity, 25%–49.9% mild heterogeneity, 50%–74.9% moderate heterogeneity, and 75%–100% considerable heterogeneity. Inverse variance statistical method was used in continuous variables data analysis, and the Mantel–Haenszel statistical method was used in discontinuous variables data analysis. Moreover, random-effects model was used for synthesis of the data. The publication biases were assessed by Egger's test for the asymmetry of funnel plots by regression methods. The presence of publication bias was indicated by Skewed and asymmetrical funnel plots. Sensitivity analyses were carried out for different subgroups according to a variety of differences in study design. All statistical analyses were executed by using Review Manager V.5.3 (RevMan, The Cochrane Collaboration, Oxford, UK). Significant differences were set at a 2-sided P value <0.05.

Results

Literature identification and study characteristics

A total of 1469 potentially eligible records were yielded from the initial database search (400 from PubMed, 878 from Embase, 191 from CENTRAL and 0 from other sources). After removing 488 duplicates, 4 independent authors screened 981 citations according to the inclusion criteria. Based on title and abstract, 954 records were excluded for various reasons (conference abstracts, letters, case reports, animal studies, pediatric patients, not RCTs in cardiac surgery, or irrelevant to the study). The remaining 27 full texts were screened, of which 10 citations were excluded for the following reasons: 3 studies had been published twice; 1 was an observational study; the full-text of 1 study was not available; and 5 studies assessed the effects of VCMs at the weaning from CPB. Finally, 17 citations were included in the meta-analysis (Fig. 1).[ The main characteristics of the included trials are described in appendix (Table S1). The assessment of risk of bias regarding included studies is shown in appendix (Fig. S2, Supplemental content).
Figure 1

Flowchart of selecting process for meta-analysis.

Flowchart of selecting process for meta-analysis.

Primary outcomes

There were 10 studies with 588 patients who reported PaO2/FiO2 ratio immediately after CPB. Our meta-analysis showed that there was a significant difference of PaO2/FiO2 between the ventilation and nonventilation groups in these studies (MD = 21.84; 95% CI = 1.30 to 42.37; P = 0.04; P for heterogeneity <0.01; I2 = 75% (Fig. 2).
Figure 2

Forest plot showing the effect of ventilation during CPB on PaO2/FiO2 ratio immediately after CPB. CPB = cardiopulmonary bypass, PaO2/FiO2 ratio = the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen.

Forest plot showing the effect of ventilation during CPB on PaO2/FiO2 ratio immediately after CPB. CPB = cardiopulmonary bypass, PaO2/FiO2 ratio = the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen. Data for the AaDO2 of ventilation during CPB were available from 10 RCTs in this analysis. Compared with the control group, ventilation during CPB was associated with significant improvement in AaDO2 immediately after weaning from CPB (MD = –50.17; 95% CI = –71.36 to –28.99; P <0.00001; P for heterogeneity <0.0001, I2 = 74%) (Fig. 3).
Figure 3

Forest plot showing the effect of ventilation during CPB on AaDO2 immediately after CPB. AaDO2 = alveolar to arterial oxygen tension difference, CPB = cardiopulmonary bypass.

Forest plot showing the effect of ventilation during CPB on AaDO2 immediately after CPB. AaDO2 = alveolar to arterial oxygen tension difference, CPB = cardiopulmonary bypass. To determine the source of heterogeneity, we made a sensitivity analysis and subgroup analysis according to ventilation strategies (Figs. 2 and 3). The sensitivity analysis showed that Alavi et al[ and Altmay et al[ separately had the greatest influence of heterogeneity on PaO2/FiO2 ratio and AaDO2. The subgroups were divided into the CPAP group and the low TV ventilation group based on the ventilation type. In the oxygenation index analysis, using CPAP during CPB showed a greater heterogeneity (I2 = 81%) than low TV ventilation (I2 = 62%). But there was no difference between 2 groups by using either CPAP (P = 0.1) or low TV ventilation strategy (P = 0.26). When it came to the AaDO2 in the subgroup analysis, there was a significant difference between 2 groups by using either CPAP (P = 0.004) or TV ventilation (P = 0.03).

Secondary outcomes

In secondary outcomes, the association between ventilation strategies during CPB and Q/Q immediately after weaning from CPB, the incidence of PPCs, hospital stay, and AaDO2 after 4 hours weaning from CPB were analyzed. The incidence of PPCs (OR = 0.79; 95% CI = 0.42 to 1.48; P = 0.46; P for heterogeneity = 0.18, I2 = 25%) and hospital stay (MD = 0.09; 95% CI = –23 to 0.41; P = 0.58; P for heterogeneity –0.16, I2 = 37%) did not differ significantly between 2 groups. However, AaDO2 4 hours after weaning from CPB (MD = –26.62; 95% CI = –48.18 to –5.06; P = 0.02; P for heterogeneity = 0.0010, I2 = 73%) and Q/Q immediately after weaning from CPB showed a significant difference between 2 groups (MD = –3.24; 95% CI = –4.48 to –2.01; P <0.00001; P for heterogeneity <0.75, I2 = 0%) (Fig. 4).
Figure 4

Forest plot showing the secondary outcomes of ventilation during CPB. CPB = cardiopulmonary bypass.

Forest plot showing the secondary outcomes of ventilation during CPB. CPB = cardiopulmonary bypass. GRADE system grades of evidence were very low for PaO2/FiO2, AaDO2 immediately after weaning from CPB, and all the secondary outcomes (Fig. S3, Supplemental content).

Discussion

The main findings of this meta-analysis were ventilation during CPB indicated an increase in oxygenation index level and a decrease in AaDO2 level immediately after weaning from CPB in patients who underwent elective cardiac surgery. In addition, shunt fraction and AaDO2 4 hours after CPB were significantly different between groups. However, the PPCs and hospital stay did not differ significantly between ventilation and nonventilation group during CPB. CPB-related pulmonary dysfunction is a multifactorial postoperative problem with high morbidity and mortality. Bignami et al[ reviewed the literature concerning CPB-related respiratory insufficiency and lung damage, concluding that correct ventilation during CPB, as a paramount part of multidisciplinary approach, might diminish the occurrence of postoperative lung injury. A meta-analysis reported by Schreiber et al[ showed that CPAP or VCMs administrated during CPB had a potential trend for lung protection based on some surrogate endpoints but no sustained effect postoperatively was found. Previous studies showed that the potential mechanisms of CPB-related lung dysfunction involved pulmonary atelectasis, intrapulmonary shunt, and change of systemic immune and inflammatory status.[ This meta-analysis examined the efficacy and safety of ventilation during CPB in patients who underwent elective cardiac surgery. It is not only an update of Schreiber et al's study but also provides different comparison direction and endpoints. On one hand, our study analyzed the combined effect of ventilation during CPB compared with the nonventilation group. On the other hand, we performed subgroup analysis to compare the impact of separate ventilation strategies (CPAP or low TV ventilation alone). But the results from the above-mentioned comparison need to be interpreted with caution. The results from the combined effect of ventilation showed that ventilation during CPB could improve PaO2/FiO2 ratio immediately after weaning from CPB (P = 0.04) but the effect from CPAP or low TV ventilation alone got an opposite conclusion (P = 0.10; 0.26). The difference might be explained by the following: sample size: all included studies were small sample size trials and the subgroup analysis made the total sample size smaller, which thus could affect the results; the influence of PEEP: the use of PEEP was not uniform in each study, so the use of PEEP might be a potential confounding factor. In order to figure out the influence of PEEP, we performed subgroup analysis based on whether PEEP was used (Fig. S4, Supplemental content). Compared with the nonventilation group, the influence of low TV ventilation with or without PEEP on the PaO2/FiO2 ratio immediately after weaning from CPB was different from each other (low TV ventilation with PEEP: MD = 54.25, 95% CI = 3.66 to 104.84, P = 0.04; low TV ventilation without PEEP: MD = –3.79, 95% CI = –23.02 to 15.45, P = 0.70). Based on this result, we could conclude that the application of PEEP might improve oxygenation after CPB when the intervention measure was low TV ventilation. None of papers about CPAP mentioned the use of PEEP so we did not perform subgroup analysis about CPAP with or without PEEP. We also performed a funnel plot to access the publication bias of the literatures. In regard to PaO2/FiO2 immediately after weaning from CPB, the symmetry of the funnel plot was not very good suggesting that there might be publication bias (Fig. S5, Supplemental content). When it came to the AaDO2 immediately after weaning from CPB, the funnel plot was symmetrical in general showing that publication bias for the included studies was controlled passably (Fig. S6, Supplemental content). A variety of lung-protective techniques, including CPAP, low TV ventilation, and VCMs, have been reported to be beneficial when applied during CPB.[ As VCM is not a continuous ventilation type and has been recommended as a lung protective strategy in clinical practice at the weaning of CPB, VCM treatment alone was excluded and we mainly discuss CPAP or low TV ventilation during CPB. And owing to the endpoints of interest in the included studies were gathered at various time points, we chose the most frequent overlapped time point (immediately after CPB) to analyze the endpoints of patients. Besides, parameter details in the intervention group were set in a large range that is trials evaluating the effect of CPAP during CPB used CPAP from 5 to 15 cmH2O. Only 1 trial used CPAP of 15 cmH2O in one of the groups but this parameter setting was too high to get a better outcome of pulmonary function.[ We just excluded these data and used a moderate CPAP from 5 to 10 cmH2O. In addition, the FiO2 used for CPAP or low TV ventilation ranged from 0.21 to 1.0. There were 2 trials that investigated the relationship of different FiO2 levels (FiO2 = 0.21; 1.0) with the PaO2/FiO2[ and they suggested that perioperative hyperoxia was potentially harmful by increasing the expression of reactive oxygen species and decreasing receptors in cells.[ Considering the lung injury caused by high FiO2, we excluded the group that using 100% oxygen in those 2 trials. When interpreting the present results, several potential limitations should be taken into consideration. To begin with, the sample sizes of many included studies were limited. Clinical trial with small size and low quality might lead to bias and high heterogeneity (Fig. S2, Supplemental content). Presently, a large-scale RCT comparing the effects of no ventilation during CPB, CPAP with a PEEP of 5 cmH2O during CPB, and low TV ventilation of 2–3 mL/kg with a PEEP of 3–5 cmH2O during CPB in cardiac surgery is being performed (clinicaltrials.gov identifier NCT02090205). Nevertheless, the comparability of eligible cites was influenced by the heterogeneity of study endpoints and protocols. Moreover, owing to long-term outcomes that were rarely reported in the eligible cites and influenced by multiple factors such as the lung protection strategies before and after CPB, the main outcomes were surrogate endpoints that were not directly linked to long-term prognosis. Only 5 trials showed the incidence of PPCs and 7 trials referred to the length of hospital stay. Thus, we could not draw the conclusion that ventilation during CPB influences long-term prognosis of patients who underwent cardiac surgery.

Conclusion

Our meta-analysis indicated that ventilation during CPB might improve post-CPB oxygenation and gas exchange in patients who were scheduled to undergo cardiac surgery. However, long-term outcomes need to be further investigated through other large-sized and high-quality clinical trials. Different respiratory parameters setting during CPB, such as low or high FiO2 values and low TV ventilation with or without PEEP, may impact clinical outcomes.

Acknowledgments

The authors sincerely thank the authors of primary clinical studies.
  31 in total

Review 1.  Pulmonary dysfunction after cardiac surgery.

Authors:  Calvin S H Ng; Song Wan; Anthony P C Yim; Ahmed A Arifi
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

2.  Ventilation during cardiopulmonary bypass: impact on heat shock protein release.

Authors:  L Beer; T Szerafin; A Mitterbauer; M M Kasiri; L Debreceni T Palotás; M Dworschak; G A Roth; H J Ankersmit
Journal:  J Cardiovasc Surg (Torino)       Date:  2013-12-17       Impact factor: 1.888

Review 3.  Lung dysfunction following cardiopulmonary bypass.

Authors:  Efstratios Apostolakis; Kriton S Filos; Efstratios Koletsis; Dimitris Dougenis
Journal:  J Card Surg       Date:  2009-06-22       Impact factor: 1.620

4.  Continued mechanical ventilation during coronary artery bypass graft operation attenuates the systemic immune response.

Authors:  Lucian Beer; Tamás Szerafin; Andreas Mitterbauer; Tamás Debreceni; Tamás Maros; Martin Dworschak; Georg A Roth; Hendrik Jan Ankersmit
Journal:  Eur J Cardiothorac Surg       Date:  2012-12-31       Impact factor: 4.191

5.  Low tidal volume ventilation during cardiopulmonary bypass reduces postoperative chemokine serum concentrations.

Authors:  Lucian Beer; Tamás Szerafin; Andreas Mitterbauer; Tamás Debreceni; Tamás Maros; Martin Dworschak; Georg A Roth; Hendrik Jan Ankersmit
Journal:  Thorac Cardiovasc Surg       Date:  2014-12-15       Impact factor: 1.827

6.  Continuous positive airway pressure does not improve lung function after cardiac surgery.

Authors:  Ece Altmay; Pelin Karaca; Nurgül Yurtseven; Vedat Ozkul; Tamer Aksoy; Azmi Ozler; Sevim Canik
Journal:  Can J Anaesth       Date:  2006-09       Impact factor: 5.063

7.  Intraoperative ventilation strategy during cardiopulmonary bypass attenuates the release of matrix metalloproteinases and improves oxygenation.

Authors:  Lucian Beer; Joanna Maria Warszawska; Peter Schenk; Tamás Debreceni; Martin Dworschak; Georg A Roth; Tamás Szerafin; Hendrik Jan Ankersmit
Journal:  J Surg Res       Date:  2014-12-17       Impact factor: 2.192

8.  Lung management during cardiopulmonary bypass: is continuous positive airways pressure beneficial?

Authors:  C B Berry; P J Butler; P S Myles
Journal:  Br J Anaesth       Date:  1993-12       Impact factor: 9.166

9.  The Effects of Positive Airway Pressure Ventilation during Cardiopulmonary Bypass on Pulmonary Function Following Open Heart Surgery.

Authors:  Mostafa Alavi; Behshid Pakrooh; Yalda Mirmesdagh; Hooman Bakhshandeh; Touraj Babaee; Saeid Hosseini; Faranak Kargar
Journal:  Res Cardiovasc Med       Date:  2013-05-20

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  11 in total

1.  Efficacy of Xuebijing Injection () on Cardiopulmonary Bypass-Associated Pulmonary Injury: A Prospective, Single-center, Randomized, Double Blinded Trial.

Authors:  Wei Gao; Na Li; Xiao-Guang Cui
Journal:  Chin J Integr Med       Date:  2018-07-31       Impact factor: 1.978

2.  Routine practice in mechanical ventilation in cardiac surgery in Italy.

Authors:  Elena Bignami; Antonio Di Lullo; Francesco Saglietti; Marcello Guarnieri; Vincenzo Pota; Sabino Scolletta; Carlo Alberto Volta; Luigi Vetrugno; Franco Cavaliere; Luigi Tritapepe
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Effect of open-lung vs conventional perioperative ventilation strategies on postoperative pulmonary complications after on-pump cardiac surgery: the PROVECS randomized clinical trial.

Authors:  David Lagier; François Fischer; William Fornier; Thi Mum Huynh; Bernard Cholley; Benoit Guinard; Bob Heger; Gabrielle Quintana; Judith Villacorta; Francoise Gaillat; Romain Gomert; Su Degirmenci; Pascal Colson; Marion Lalande; Samir Benkouiten; Tam Hoang Minh; Matteo Pozzi; Frederic Collart; Christian Latremouille; Marcos F Vidal Melo; Lionel J Velly; Samir Jaber; Jean-Luc Fellahi; Karine Baumstarck; Catherine Guidon
Journal:  Intensive Care Med       Date:  2019-10-01       Impact factor: 17.440

4.  A perioperative surgeon-controlled open-lung approach versus conventional protective ventilation with low positive end-expiratory pressure in cardiac surgery with cardiopulmonary bypass (PROVECS): study protocol for a randomized controlled trial.

Authors:  David Lagier; François Fischer; William Fornier; Jean-Luc Fellahi; Pascal Colson; Bernard Cholley; Samir Jaber; Karine Baumstarck; Catherine Guidon
Journal:  Trials       Date:  2018-11-13       Impact factor: 2.279

5.  The Effect of Continuous Ventilation on Thiol-Disulphide Homeostasis and Albumin-Adjusted Ischemia-Modified Albumin During Cardiopulmonary Bypass.

Authors:  Seyda Efsun Ozgunay; Kadir Kaan Ozsin; Yasemin Ustundag; Derya Karasu; Buket Ozyaprak; Burak Balcı; Ozcan Erel; Senol Yavuz
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27

6.  A human model of bilateral pulmonary vein sampling to assess the effects of one-lung ventilation on neutrophil function.

Authors:  Wendy Funston; Marie-Hélène Ruchaud-Sparagano; Jonathan Scott; Jason Powell; Faye A H Cooles; Lauren Shelmerdine; Cliona McDowell; Denis O'Leary; Karen L Booth; Stephen C Clark; Simon J Ledingham; Anthony J Rostron; John H Dark; A John Simpson
Journal:  PLoS One       Date:  2022-07-26       Impact factor: 3.752

7.  Intraoperative lung-protective ventilation in cardiothoracic surgeries: Paradigm and practices.

Authors:  Praveen K Neema; Naveen Malhotra; Rudrashish Haldar; Habib M R Karim
Journal:  Indian J Anaesth       Date:  2021-05-10

8.  Low tidal volume mechanical ventilation against no ventilation during cardiopulmonary bypass heart surgery (MECANO): study protocol for a randomized controlled trial.

Authors:  Lee S Nguyen; Messaouda Merzoug; Philippe Estagnasie; Alain Brusset; Jean-Dominique Law Koune; Stephane Aubert; Thierry Waldmann; Jean-Michel Grinda; Hadrien Gibert; Pierre Squara
Journal:  Trials       Date:  2017-12-02       Impact factor: 2.279

9.  Ventilation strategies with different inhaled Oxygen conceNTration during CardioPulmonary Bypass in cardiac surgery (VONTCPB): study protocol for a randomized controlled trial.

Authors:  Meng-Qiu Zhang; Yu-Qi Liao; Hong Yu; Xue-Fei Li; Liang Feng; Xiao-Yun Yang; Hai Yu
Journal:  Trials       Date:  2019-05-03       Impact factor: 2.279

10.  Protective continuous ventilation strategy during cardiopulmonary bypass in children undergoing surgery for congenital heart disease: a prospective study.

Authors:  Massimo A Padalino; Luca Vedovelli; Manuela Simonato; Andrea Bandini; Greta Paganini; Laura Mezzalira; Nicola Faganello; Cristiana Carollo; Dario Gregori; Vladimiro Vida; Paola Cogo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.